Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Athanassios Argiris

Showing results (81-90 of 122) with videos related to

Pageof 13
Sort By:
Cancer|August 8, 2008
Evaluating the supportive care costs of severe radiochemotherapy-induced mucositis and pharyngitis : results from a Northwestern University Costs of Cancer Program pilot study with head and neck and nonsmall cell lung cancer patients who received care at a county hospital, a Veterans Administration hospital, or a comprehensive cancer care centerNarissa J Nonzee, Neal A Dandade, Urjeet Patel, et al.
Cancers|March 10, 2022
Targeting Angiogenesis in Squamous Cell Carcinoma of the Head and Neck: Opportunities in the Immunotherapy EraNabil F Saba, Pooja Vijayvargiya, Jan B Vermorken, et al.
The Laryngoscope|October 9, 2007
Deferring planned neck dissection following chemoradiation for stage IV head and neck cancer: the utility of PET-CTJayakar V Nayak, Rohan R Walvekar, Regiane S Andrade, et al.
The Laryngoscope|September 20, 2022
CD8+ and FoxP3+ T-Cell Cellular Density and Spatial Distribution After Programmed Death-Ligand 1 Check Point InhibitionJoseph Curry, Angela Alnemri, Ramez Philips, et al.
Cancer|October 3, 2023
Effect of preoperative programmed death-1 or programmed death ligand-1 immune check point inhibition on complications after surgery for primary head and neck cancerRamez Philips, Angela Alnemri, Dev Amin, et al.
Head & Neck|May 4, 2004
Neck dissection in the combined-modality therapy of patients with locoregionally advanced head and neck cancerAthanassios Argiris, Kerstin M Stenson, Bruce E Brockstein, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 5, 2016
Phase I Results from a Study of Crizotinib in Combination with Erlotinib in Patients with Advanced Nonsquamous Non-Small Cell Lung CancerSai-Hong Ignatius Ou, Ramaswamy Govindan, Keith D Eaton, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|March 13, 2016
Emerging aspects of nanotoxicology in health and disease: From agriculture and food sector to cancer therapeuticsZoi Piperigkou, Konstantina Karamanou, Ayse Basak Engin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 17, 2003
Induction chemotherapy followed by concomitant TFHX chemoradiotherapy with reduced dose radiation in advanced head and neck cancerDaniel J Haraf, Fred R Rosen, Kerstin Stenson, et al.
The Laryngoscope|October 31, 2009
Management of patients treated with chemoradiotherapy for head and neck cancer without prophylactic feeding tubes: the University of Pittsburgh experienceBrian T McLaughlin, Abhay S Gokhale, Yongli Shuai, et al.
Pageof 13

Showing results (81-90 of 122) with videos related to

Sort By:
Pageof 13
Cancer|August 8, 2008
Evaluating the supportive care costs of severe radiochemotherapy-induced mucositis and pharyngitis : results from a Northwestern University Costs of Cancer Program pilot study with head and neck and nonsmall cell lung cancer patients who received care at a county hospital, a Veterans Administration hospital, or a comprehensive cancer care centerNarissa J Nonzee, Neal A Dandade, Urjeet Patel, et al.
Cancers|March 10, 2022
Targeting Angiogenesis in Squamous Cell Carcinoma of the Head and Neck: Opportunities in the Immunotherapy EraNabil F Saba, Pooja Vijayvargiya, Jan B Vermorken, et al.
The Laryngoscope|October 9, 2007
Deferring planned neck dissection following chemoradiation for stage IV head and neck cancer: the utility of PET-CTJayakar V Nayak, Rohan R Walvekar, Regiane S Andrade, et al.
The Laryngoscope|September 20, 2022
CD8+ and FoxP3+ T-Cell Cellular Density and Spatial Distribution After Programmed Death-Ligand 1 Check Point InhibitionJoseph Curry, Angela Alnemri, Ramez Philips, et al.
Cancer|October 3, 2023
Effect of preoperative programmed death-1 or programmed death ligand-1 immune check point inhibition on complications after surgery for primary head and neck cancerRamez Philips, Angela Alnemri, Dev Amin, et al.
Head & Neck|May 4, 2004
Neck dissection in the combined-modality therapy of patients with locoregionally advanced head and neck cancerAthanassios Argiris, Kerstin M Stenson, Bruce E Brockstein, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 5, 2016
Phase I Results from a Study of Crizotinib in Combination with Erlotinib in Patients with Advanced Nonsquamous Non-Small Cell Lung CancerSai-Hong Ignatius Ou, Ramaswamy Govindan, Keith D Eaton, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|March 13, 2016
Emerging aspects of nanotoxicology in health and disease: From agriculture and food sector to cancer therapeuticsZoi Piperigkou, Konstantina Karamanou, Ayse Basak Engin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 17, 2003
Induction chemotherapy followed by concomitant TFHX chemoradiotherapy with reduced dose radiation in advanced head and neck cancerDaniel J Haraf, Fred R Rosen, Kerstin Stenson, et al.
The Laryngoscope|October 31, 2009
Management of patients treated with chemoradiotherapy for head and neck cancer without prophylactic feeding tubes: the University of Pittsburgh experienceBrian T McLaughlin, Abhay S Gokhale, Yongli Shuai, et al.
Pageof 13